Valuation: Star Scientific, Inc.

Market Cap 153K 134K 123K 114K 218K 14.63M 220K 1.48M 574K 7.18M 576K 563K 24.85M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.48M 16.1M 14.93M 28.42M 1.91B 28.76M 192M 74.92M 937M 75.14M 73.49M 3.24B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-1.14%-0.67%+53.72%+157.69% 1,082B
-1.41%+1.83%+66.23%+59.28% 633B
-2.42%+0.56%+34.59%+85.12% 461B
-0.26%+1.37%+31.00%+23.05% 338B
-2.46%-1.52%+36.42%+32.77% 299B
-2.20%-0.93%+27.50%+40.62% 291B
-1.77%+0.99%-28.85%-41.41% 222B
-2.06%+2.26%+22.87%+62.23% 202B
-1.26%+1.35%+15.98%+67.80% 163B
Average -0.60%+4.45%+28.83%+54.13% 410.27B
Weighted average by Cap. -0.04%+5.43%+39.61%+78.91%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.65M -31M -28.75M -54.71M -3.67B -55.35M -370M -144M -1.8B -145M -141M -6.24B -6.84M -5.98M -5.51M -5.11M -9.72M -653M -9.84M -65.84M -25.63M -320M -25.7M -25.14M -1.11B
Net Debt -45K -39.31K -36.21K -33.58K -63.92K -4.29M -64.67K -433K -168K -2.11M -169K -165K -7.29M 19.86M 17.35M 15.98M 14.82M 28.21M 1.89B 28.54M 191M 74.35M 930M 74.56M 72.93M 3.22B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-